Webinar: InMed Pharmaceuticals

Published on 5 May 2021

InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs.

In this webinar, CEO Eric Adams and CFO Bruce Colwill present an overview of the company’s recent operating and financial activities. A brief Q&A session follows the presentation.

Share this with friends and colleagues